Topic: Biotechnology
By Elizabeth Lopatto . . Sanofi-Aventis SA may need to raise its bid for Genzyme Corp. to at least $75 a share, or about $19.1 billion, to gain ...
Recognizing the strong commercial opportunities for its services in Europe, Caris Life Sciences , a leading biosciences company focused on driving...
Shares of the following companies were making notable moves in premarket action on Thursday: . . ATS Corp. (ATSC 2.70, -0.05, -1.82%) shares gained...
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital, along with a...
Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael M. Morrissey, PhD, the company's president and chief executive officer, will present at...
Synthetic biology -- defined as the design and construction of new biological parts, devices, and systems or re-design of existing natural...
A new poll conducted by Hart Research Associates and the Synthetic Biology Project at the Woodrow Wilson Center finds that two-thirds of Americans...
In the Sept. 9 issue of Neuron, Neurogenetic Pharmaceuticals reports proof of concept studies that show its proprietary compound, NGP 555, is...
cortex writes with an excerpt from the L.A. Times: "In a first step toward helping severely paralyzed people communicate more easily, Utah...
Using a moving 3-D computer model based on the skull and teeth of a New Zealand reptile called tuatara, a BBSRC-funded team from the University of...